Myeloma and the newly diagnosed patient

A focus on treatment and management

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

An evidence-based approach to the management of newly diagnosed multiple myeloma, developed at the Mayo Clinic (Rochester, MN), is summarized in this article. The optimum pretransplant induction regimen for multiple myeloma is described, and outcomes for early and delayed transplantation, one versus two transplants, the role of thalidomide in smoldering multiple myeloma, and the role of maintenance therapy are discussed. The role of supportive care strategies for patients with bone disease, such as the use of bisphosphonates, is also discussed.

Original languageEnglish (US)
Pages (from-to)5-10
Number of pages6
JournalSeminars in Oncology
Volume29
Issue number6 SUPPL. 17
DOIs
StatePublished - Dec 2002

Fingerprint

Multiple Myeloma
Thalidomide
Bone Diseases
Diphosphonates
Patient Care
Therapeutics
Transplantation
Transplants

ASJC Scopus subject areas

  • Oncology

Cite this

Myeloma and the newly diagnosed patient : A focus on treatment and management. / Rajkumar, S Vincent; Kyle, Robert A.; Gertz, Morie.

In: Seminars in Oncology, Vol. 29, No. 6 SUPPL. 17, 12.2002, p. 5-10.

Research output: Contribution to journalArticle

@article{55278118da2c4b7180dd0e07054ad5f6,
title = "Myeloma and the newly diagnosed patient: A focus on treatment and management",
abstract = "An evidence-based approach to the management of newly diagnosed multiple myeloma, developed at the Mayo Clinic (Rochester, MN), is summarized in this article. The optimum pretransplant induction regimen for multiple myeloma is described, and outcomes for early and delayed transplantation, one versus two transplants, the role of thalidomide in smoldering multiple myeloma, and the role of maintenance therapy are discussed. The role of supportive care strategies for patients with bone disease, such as the use of bisphosphonates, is also discussed.",
author = "Rajkumar, {S Vincent} and Kyle, {Robert A.} and Morie Gertz",
year = "2002",
month = "12",
doi = "10.1053/sonc.2002.34070",
language = "English (US)",
volume = "29",
pages = "5--10",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "6 SUPPL. 17",

}

TY - JOUR

T1 - Myeloma and the newly diagnosed patient

T2 - A focus on treatment and management

AU - Rajkumar, S Vincent

AU - Kyle, Robert A.

AU - Gertz, Morie

PY - 2002/12

Y1 - 2002/12

N2 - An evidence-based approach to the management of newly diagnosed multiple myeloma, developed at the Mayo Clinic (Rochester, MN), is summarized in this article. The optimum pretransplant induction regimen for multiple myeloma is described, and outcomes for early and delayed transplantation, one versus two transplants, the role of thalidomide in smoldering multiple myeloma, and the role of maintenance therapy are discussed. The role of supportive care strategies for patients with bone disease, such as the use of bisphosphonates, is also discussed.

AB - An evidence-based approach to the management of newly diagnosed multiple myeloma, developed at the Mayo Clinic (Rochester, MN), is summarized in this article. The optimum pretransplant induction regimen for multiple myeloma is described, and outcomes for early and delayed transplantation, one versus two transplants, the role of thalidomide in smoldering multiple myeloma, and the role of maintenance therapy are discussed. The role of supportive care strategies for patients with bone disease, such as the use of bisphosphonates, is also discussed.

UR - http://www.scopus.com/inward/record.url?scp=0037252631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037252631&partnerID=8YFLogxK

U2 - 10.1053/sonc.2002.34070

DO - 10.1053/sonc.2002.34070

M3 - Article

VL - 29

SP - 5

EP - 10

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 6 SUPPL. 17

ER -